Nuclear organization of PML bodies in leukaemic and multiple myeloma cells

被引:16
|
作者
Krejci, Jana [1 ]
Harnicarova, Andrea [1 ]
Kurova, Jana [1 ]
Uhlirova, Radka [1 ]
Kozubek, Stanislav [1 ]
Legartova, Sona [1 ]
Hajek, Roman [2 ]
Bartova, Eva [1 ]
机构
[1] Acad Sci Czech Republic, Inst Biophys, CZ-61265 Brno, Czech Republic
[2] Masaryk Univ Hosp, Dept Internal Med Hematooncol, Brno 62500, Czech Republic
关键词
PML bodies; Nuclear arrangement; Leukaemic cells; Multiple myeloma cells;
D O I
10.1016/j.leukres.2008.04.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The nuclear arrangement of promyelocytic leukaemia nuclear bodies (PML NBs) was studied in vitro after the cell treatment by clinically used agents such as all-trans retinoic acid (RA) in human leukaemia and cytostatics or gamma radiation in multiple myeloma cells. In addition, the influence of phorbol ester (PMA) on PML NBs formation was analyzed. A reduced number of PML bodies, which led to relocation of PML NBs closer to the nuclear interior, mostly accompanied RA- and PMA-induced differentiation. Centrally located PML NBs were associated with transcriptional protein RNAP 11 and SC35 regions, which support importance of PML NBs in RNA processing that mostly proceeds within the nuclear interior. Conversely, the quantity of PML NBs was increased after cytostatic treatment, which caused re-distribution of PML NBs closer to the nuclear envelope. Here we showed correlations between the number of PML NBs and average Centre-to-PML distances. Moreover, a number of cells in S phase, especially during differentiation, influenced number of PML NBs. Studying the proteins involved in PML compartment, such as c-MYC, cell-type specific association of c-MYC and the PML NBs was observed in selected leukaemic cells undergoing differentiation, which was accompanied by c-MYC down-regulation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1866 / 1877
页数:12
相关论文
共 50 条
  • [1] PML Nuclear Bodies
    Lallemand-Breitenbach, Valerie
    de The, Hugues
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (05): : a000661
  • [2] PML nuclear bodies and apoptosis
    Takahashi, Y
    Lallemand-Breitenbach, V
    Zhu, J
    de Thé, H
    ONCOGENE, 2004, 23 (16) : 2819 - 2824
  • [3] PML nuclear bodies and apoptosis
    Yuki Takahashi
    Valérie Lallemand-Breitenbach
    Jun Zhu
    Hugues de Thé
    Oncogene, 2004, 23 : 2819 - 2824
  • [4] PML and PML nuclear bodies: Implications in antiviral defence
    Everett, Roger D.
    Chelbi-Alix, Mounira K.
    BIOCHIMIE, 2007, 89 (6-7) : 819 - 830
  • [5] Viruses as hijackers of PML nuclear bodies
    Möller, A
    Schmitz, ML
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (05) : 295 - 300
  • [6] The PML nuclear bodies: actors or extras?
    Seeler, JS
    Dejean, A
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (03) : 362 - 367
  • [7] New advances in regulation of senescence by PML and the PML nuclear bodies
    Aauino, Mariana D. Acevedo
    Bourdeau, Veronique
    Vernier, Mathieu
    Ferbeyre, Gerardo
    CANCER RESEARCH, 2012, 72
  • [8] c-Myb associates with PML in nuclear bodies in hematopoietic cells
    Dahle, O
    Bakke, O
    Gabrielsen, OS
    EXPERIMENTAL CELL RESEARCH, 2004, 297 (01) : 118 - 126
  • [9] Association of PML Expression with Chemotherapy-Resistance In Multiple Myeloma Cells
    Ohgiya, Daisuke
    Onizuka, Makoto
    Matsushita, Hiromichi
    Nakamura, Naoya
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Ando, Kiyoshi
    BLOOD, 2010, 116 (21) : 1220 - 1221
  • [10] PML nuclear bodies: from architecture to function
    Lallemand-Breitenbach, Valerie
    de The, Hugues
    CURRENT OPINION IN CELL BIOLOGY, 2018, 52 : 154 - 161